Cyclotek extemporaneously compounds PET Radiopharmaceuticals made to order by customers for particular persons.
Supply mechanisms for FDG follow a standard product supply agreement, whereas other products are supplied under a Clinical Trial / Contract Manufacturing Agreement(s) or utilising the TGA Special Access Scheme or Authorised Prescriber rules.
None of the products being available for supply to the general public, and are only available to hospitals, doctors and certain other authorised persons.
In addition to the above, Cyclotek and the imaging site need to have a Supply Agreement in place. This can be in one of several formats, which we would be glad to discuss with you. We can also provide you with more detailed information on the regulatory requirements mentioned aboveN
[contact-form-7 id=”714″ title=”Update Form”]